Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,934 | -12,022 | -4,962 | -19,815 | -14,737 |
| Depreciation Amortization | 92 | 61 | 31 | 207 | 162 |
| Accounts receivable | -758 | 164 | 175 | -175 | -50 |
| Accounts payable and accrued liabilities | 2,707 | 90 | -425 | 457 | -567 |
| Other Working Capital | 2,830 | 1,159 | -238 | -11 | -313 |
| Other Operating Activity | -1,579 | 1 | 379 | 263 | 1,030 |
| Operating Cash Flow | $-13,642 | $-10,547 | $-5,040 | $-19,074 | $-14,475 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -49 | -49 | -99 | -101 |
| Investing Cash Flow | $-67 | $-49 | $-49 | $-99 | $-101 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -57 | -38 | -19 | -75 | -56 |
| Common Stock Issued | 7,502 | 6,151 | 2,040 | 17,050 | 13,229 |
| Financing Cash Flow | $7,445 | $6,113 | $2,021 | $16,975 | $13,173 |
| Beginning Cash Position | 6,391 | 6,391 | 6,391 | 8,589 | 8,589 |
| End Cash Position | 127 | 1,908 | 3,323 | 6,391 | 7,186 |
| Net Cash Flow | $-6,264 | $-4,483 | $-3,068 | $-2,198 | $-1,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,642 | -10,547 | -5,040 | -19,074 | -14,475 |
| Capital Expenditure | -67 | -49 | -49 | -99 | -101 |
| Free Cash Flow | -13,709 | -10,596 | -5,089 | -19,173 | -14,576 |